Hepatocellular Carcinoma Risk Persists In HCV Patients With Another Malignancy - Gastroenterology & Endoscopy News
/Gastroenterology & Endoscopy News Chicago
Patients with hepatitis C who develop both a liver cancer and a non-liver malignancy appear to respond poorly to traditional antiviral therapies such as pegylated interferon and ribavirin, according to an analysis from a large U.S. cancer center. ...>
from HCV - Google News http://ift.tt/10dZuCB via IFTTT